Working… Menu

Active Surveillance With or Without Apalutamide Treatment in Low Risk Prostate Cancer (PC-ARN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03088124
Recruitment Status : Recruiting
First Posted : March 23, 2017
Last Update Posted : September 27, 2019
Janssen-Cilag Ltd.
Information provided by (Responsible Party):
Institut Paoli-Calmettes

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : April 28, 2022
Estimated Study Completion Date : April 28, 2022